Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Dietary Supplements Among Cancer Patients: Tolerance and Impact on Medications and Drug Interactions Assessed Using the Hedrine Software

NCT07670234 is registered in ClinicalTrials.gov with Centre Mohammed VI de la Recherche et de l'Innovation (CM6RI) as lead sponsor.

NCT NCT07670234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07670234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Dietary Supplements Among Cancer Patients: Tolerance and Impact on Medications and Drug Interactions Assessed Using the Hedrine Software
Lead sponsor
Centre Mohammed VI de la Recherche et de l'Innovation (CM6RI)
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2025
Completion date
December 31, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer (solid tumors), interaction drug food